United States · Funded startup

Who invested in Imara

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$113Mraised across 2 rounds since 2019, from 2 sources

$63MSeries B$50MRound
Latest round
Round, $50MJul 2021
Biggest round
$63MSeries B · Mar 2019
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20202021
$63MSeries B$50MRound
First round
Series B, $63M
Mar 2019
Biggest round
$63M
Series B · Mar 2019
Between rounds
2.3 years
from the last two

The rounds

  1. Jul 2021
  2. Mar 2019
    Series B$63M1 new

    Reported by PharmiwebSEC filing: $44M sold, first sale Mar 2019

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

OrbiMedPrivate equity1round
RA Capital ManagementPrivate equity1round
ArixVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Imara

Who invested in Imara?

Imara's investors include New Enterprise Associates, OrbiMed, RA Capital Management and Arix.

How much has Imara raised?

Imara has raised $113M across 2 rounds since 2019.

When did Imara last raise?

Imara's most recent round was an Undisclosed round of $50M in Jul 2021.

What was Imara's biggest round?

Imara's largest round on record is $63M (Series B), in Mar 2019.

Who backed Imara first?

Imara's first round on record, in Mar 2019, was backed by Arix.

What stage is Imara at?

Imara's latest named round is an Undisclosed round, in Jul 2021.

Where is Imara based?

Imara is based in the United States.

Companies like Imara

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.